3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials

BACKGROUND: Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder of neuromuscular transmission. The objective was to examine the efficacy and safety of 3,4-diaminopyridine (3,4-DAP) in patients with LEMS. METHODS: We searched several databases to identify relevant studies, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Na, Hong, Daojun, Ouyang, Taohui, Meng, Wei, Huang, Jingwei, Li, Meihua, Hong, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464094/
https://www.ncbi.nlm.nih.gov/pubmed/34563155
http://dx.doi.org/10.1186/s12883-021-02405-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464094/
https://www.ncbi.nlm.nih.gov/pubmed/34563155
http://dx.doi.org/10.1186/s12883-021-02405-3

Ejemplares similares